St. Jude Children’s Research Hospital data scientist Deo Kumar Srivastava, Ph.D., has been elected as a fellow of the American Statistical Association (ASA), the largest and oldest professional statistical organization in the world. Srivastava was selected for his outstanding contributions toward advancing pediatric cancer research using sound biostatistical methods, providing leadership and mentoring, for excellent and sustained contributions to the field of statistical methods, and for dedicated service to the profession, according to his fellowship citation.
Srivastava, a member of the St. Jude Department of Biostatistics, has served as the lead statistician for many clinical studies during his long tenure at the institution, including many that emanated from St. Jude LIFE and the Childhood Cancer Survivor Study (CCSS). St. Jude LIFE is an unprecedented research study that brings long-term childhood cancer survivors back to St. Jude for regular health screenings throughout their adult lives. The CCSS is a multi-institutional study led by St. Jude that examines the long-term effects of cancer therapy on pediatric patients.
“It is a great honor for the ASA to recognize my work in this way,” said Srivastava, who joined St. Jude in 1993. “Joining this fellowship is one of the highest honors in our profession.”
“We are thrilled that Dr. Srivastava has been selected as a fellow of the ASA,” said Motomi Mori, Ph.D., St. Jude Department of Biostatistics chair, ASA fellow, and newly elected member of the ASA board of directors. “This is a well-deserved honor, highlighting his impactful contributions to the design and analysis of childhood cancer survivorship studies and his biostatistical leadership in survivorship research.”
Notable past ASA members and fellows include the eighth President of the United States Martin Van Buren; scientist Alexander Graham Bell (who was first to patent the telephone); social reformer and founder of modern nursing Florence Nightingale; Nobel laureate Milton Friedman; and Federal Reserve Chair Alan Greenspan.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress blog, and follow St. Jude on social media at @stjuderesearch.